Rebounded from its bottom several days ago, the stock price is currently traded above its bearish channel’s resistance. We could assume the trend is reversing and the stock price would start to rise again after it retouch its new support at around $45.84.
EBS: Emergent BioSolutions
2019-07-30 16:42:29
Emergent BioSolutions Announces Exercise by BARDA of the First Contract Option, Valued at $261 Million, to Procure Doses of AV7909 Anthrax Vaccine Candidate for the Strategic National Stockpile
EBS: Emergent BioSolutions
2019-06-04 16:05:00
Emergent BioSolutions Announces FDA Approval of Change in Storage Conditions and Transfer of Manufacturing for Its Cholera Vaccine - GlobeNewswire
EBS: Emergent BioSolutions
2019-06-03 06:30:00
Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness - GlobeNewswire
3 reversal and bullish candlesticks at trendline bounce. Volume spike and stoch curling out of oversold. In a good industry too.
discord.gg join this discord for a candlestick swing trading group
EBS: Emergent BioSolutions
2019-02-28 16:45:43
Emergent BioSolutions Awarded U.S. Department of State Contract to Supply Medical Countermeasures For Chemical Warfare Agents
